Article Abstract
Sir: Risperidone is a serotonin-2/dopamine-2 (5-HT2/D2) receptor antagonist that has demonstrated efficacy in the treatment of schizophrenia. It has also been suggested to possess acute antimanic effects in some patients. Other preliminary data, however, indicate that risperidone may initiate or exacerbate manic symptoms owing to its putative antidepressant activity.
From the Editors
Are you a healthcare provider?
Add your NPI to personalize your JCP experience.
Download Free PDF
This PDF is free for all visitors!
